2003

Oct 21, 2003
Guidant Licenses Innovative Tissue-Welding Technology for Cardiac Surgery

Agreement Reinforces Guidant''s Leadership in Endoscopic Cardiovascular Technologies Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...

Oct 16, 2003
Guidant Reports Record Third Quarter Sales of $938 million, 15 Percent Sales Growth

* Worldwide implantable defibrillator revenue of $385 million, up 48 percent * Worldwide stent revenue of $200 million, down 14 percent * Gross margin increases to 76.1 percent * Drug eluting...

Oct 9, 2003
Guidant Announces Live Webcast of its Third Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its third quarter 2003 earnings conference...

Oct 8, 2003
Guidant Initiates Voluntary Recall of 3.0 mm-Diameter MULTI-LINK VISION Coronary Stent System

Company Resumes Product Shipment with Food and Drug Administration Approval Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...

Oct 6, 2003
Guidant Announces European Approval and First Implant of Next Generation Heart Failure Therapy System

Cardiac Resynchronization Therapy Defibrillator Represents the World''s Thinnest, Most Advanced System Brussels, Belgium and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in...

Oct 2, 2003
Guidant Appoints Beverly H. Lorell, M.D., Vice President, Chief Medical and Technology Officer

New Position Will Lead Technology Development Strategy INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Beverly...

Sep 23, 2003
COMPANION Trial Results to be Announced During Late Breaking Scientific Session at the Heart Failure Society of America 7th Annual Scientific Meeting

Updated Landmark Heart Failure Trial Data Submitted to Peer-Reviewed Journal LAS VEGAS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...

Sep 23, 2003
Guidant Completes Enrollment in Clinical Investigation of New Therapy for Stroke Prevention

Second Clinical Trial Advances Efforts to Develop Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world...

Sep 19, 2003
Guidant's Institute for Therapy Advancement Europe Welcomes 5,000th Participant

Institute Demonstrates Guidant''s Leadership in Medical Education Brussels, Belgium - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...

Sep 18, 2003
David E. Kandzari, M.D., Wins First Annual Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award

Guidant-Supported Grant Honors Late Chief Medical Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced...

Sep 18, 2003
Guidant Announces Additional Findings of Key Study In Emerging Field of Heart Attack Prevention

Vulnerable Plaque Study Shows Correlation Between Lipid-Rich Plaques and Heart Attacks in Cath Lab Patients Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...

Sep 17, 2003
Guidant Reports Positive Results of Two Everolimus Eluting Coronary Stent Clinical Trials

FUTURE I and II Trials Utilize Everolimus with Bioabsorbable Polymer; Results Presented Today Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Sep 11, 2003
Guidant to Host Investor Briefing at Transcatheter Cardiovascular Therapeutics Meeting

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will host an investor briefing...

Sep 4, 2003
Guidant to Participate in Bear Stearns 16th Annual Healthcare Conference

Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...

Sep 2, 2003
Guidant Acquires Innovative Polymer Technology for Drug Eluting Stent Program

"Programmable" Polymer Capabilities Strengthen Guidant''s Development of Future Therapies for Coronary Artery Disease Indianapolis and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a...

Aug 26, 2003
Guidant Announces Share Repurchase at Mid-Quarter Conference Call Today

Company Outlines Progress Toward Drug Eluting Stent Milestones; Third Quarter and Full-Year 2003 Financial Guidance Affirmed Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in...

Aug 20, 2003
Guidant Increases Investment in Innovator of Heart Surgery Devices

Additional Equity Investment Strengthens Guidant''s Commitment to the Development of Future Technologies for Heart Surgery Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world leader in...

Aug 20, 2003
Guidant to Host Mid-Quarter Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will host a mid-quarter conference call to provide an update on the...

Aug 19, 2003
Guidant Announces Third Quarter Dividend

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company''s board of directors declared a third...

Jul 21, 2003
Guidant Announces European Market Launch of its Most Advanced Pacemaker Line

Latest Addition to Pacemaker Portfolio Offers Improved Therapy Options While Maintaining Size and Longevity Brussels, Belgium and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader...

Jul 18, 2003
Guidant Urges Conferees to Move Swiftly on Medicare Reform

Calls on Conference to Seize Historic Opportunity to Improve Quality and Expand Access Through Greater Choice, Competition and Innovation Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a...

Jul 17, 2003
Guidant Announces U.S. Approval of Newest Implantable Defibrillator for the Treatment of Irregular Heart Rhythms

World''s Smallest Dual Chamber System Offers Enhanced Therapies to Patients at Risk of Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader...

Jul 17, 2003
Guidant Reports Record Sales of $945 Million in Second Quarter, Growth of 20 Percent

Worldwide implantable cardioverter defibrillator revenues of $377 million, up 50 percent; Worldwide stent revenue of $224 million, down 2 percent; Favorable product mix generates 75.4 percent...

Jul 16, 2003
Guidant Receives U.S. Approval for First Cobalt Chromium Coronary Stent System

Next-Generation Stent Design and Excellent Clinical Results Offer Expanded Treatment Options for Patients Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...

Jul 14, 2003
New Study Shows Excellent Six-Month Results for Guidant's Market-Leading Small Vessel Stent

European Trial Demonstrates Low Restenosis Rate in Stenting of Small Vessels Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...

Show 5102550100 per page
Top